Detalhe da pesquisa
1.
High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients.
Breast Cancer Res
; 25(1): 139, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946261
2.
Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness.
Breast Cancer Res
; 25(1): 69, 2023 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37316882
3.
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study.
Breast Cancer Res Treat
; 198(1): 103-112, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576678
4.
Digital image analysis and assisted reading of the HER2 score display reduced concordance: pitfalls in the categorisation of HER2-low breast cancer.
Histopathology
; 82(6): 912-924, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737248
5.
Neo-train: study protocol and feasibility results for a two-arm randomized controlled trial investigating the effect of supervised exercise during neoadjuvant chemotherapy on tumour response in patients with breast cancer.
BMC Cancer
; 23(1): 777, 2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598196
6.
Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer.
Acta Oncol
; 62(12): 1913-1920, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961947
7.
Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide study.
Breast Cancer Res Treat
; 196(1): 197-206, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36076126
8.
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.
Mod Pathol
; 35(10): 1362-1369, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729220
9.
Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer.
Br J Cancer
; 125(10): 1388-1398, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34365471
10.
Peripheral blood immune markers in breast cancer: Differences in regulatory T cell abundance are related to clinical parameters.
Clin Immunol
; 232: 108847, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34506945
11.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
; 250(5): 667-684, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32129476
12.
Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial.
Breast Cancer Res
; 22(1): 46, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410705
13.
Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.
Br J Cancer
; 123(11): 1608-1615, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939053
14.
Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients.
Breast Cancer Res Treat
; 184(1): 123-133, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748297
15.
Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial.
Int J Cancer
; 144(10): 2578-2586, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411790
16.
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Histopathology
; 75(2): 225-235, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31017314
17.
The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer.
Breast Cancer Res
; 20(1): 79, 2018 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30053900
18.
Mortality and recurrence rates among systemically untreated high risk breast cancer patients included in the DBCG 77 trials.
Acta Oncol
; 57(1): 135-140, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168407
19.
The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes.
Acta Oncol
; 57(1): 44-50, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29202609
20.
The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016.
Acta Oncol
; 57(1): 13-18, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29202621